[1]
M. Prada, L. Rossi, and M. Mantovani, “Time to reimbursement and negotiation condition in Italy for drugs approved by the European Medicines Agency during the period 2014-2019”, AboutOpen, vol. 7, no. 1, pp. 89–94, Dec. 2020.